|
|
|
|
|
|
|
|
|
|
October 8, 2010 (Milan, Italy) — A record number of abstracts were submitted and accepted, and a record number of attendees expected, here at the 35th European Society for Medical Oncology Congress. In addition, findings from major phase 3 trials may change clinical practice in lung, breast, ovarian, and prostate cancer.....
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.